Improve MRI Diagnosis

Evaluation of Advanced and New MRI Techniques to Improve Patient Diagnosis

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05744102

Acronym

DIAGIRM

Enrollment

2016

Registered

2023-02-24

Start date

2023-03-15

Completion date

2030-03-15

Last updated

2023-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New MRI Techniques

Keywords

Advanced MRI

Brief summary

The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.

Detailed description

The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence. The decision criterion for considering a new sequence as superior to the standard sequence will be based on two measures: 1. The proportion of patients for whom the new sequence was preferred, which must be greater than or equal to 75%; 2. Inter-observer agreement (Cohen's Kappa coefficient), which must be greater than or equal to 0.8; When these two criteria are met, the new sequence will be considered superior to the standard sequence

Interventions

DIAGNOSTIC_TESTMRI Image

MRI sequences

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Adult patient * Patient who signed a consent to participate in the study * Affiliated patient or beneficiary of a social security scheme * Patient having an MRI scheduled as part of their care pathway * Absence of prohibition of participation in another research

Exclusion criteria

* Patients under guardianship or curators * Pregnant or breastfeeding patients * Patients responding to a contraindication to performing an MRI * Patient under state medical aid (AME) * Adult patients protected by law

Design outcomes

Primary

Measure	Time frame	Description
Image quality	7 years	The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence.

Secondary

Measure	Time frame	Description
Acquisition period	7 years	Average acquisition time
Apnea	7 years	Proportion of patients for whom apnea was requested.

Countries

France

Contacts

Primary ContactMaïté LEWIN, MD, PHD

maite.lewin@aphp.fr(33) 06 11 15 06 17

Backup ContactJean-manuel DA-MOTA-FERREIRA, Radiologic Technologist

'jean-manuel.da-mota-ferreira@aphp.fr(33) 01 45 59 35 26

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026